Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Revenue (2022 - 2025)

Cannabis Bioscience International Holdings' Revenue history spans 4 years, with the latest figure at $53266.0 for Q4 2025.

  • For Q4 2025, Revenue fell 28.26% year-over-year to $53266.0; the TTM value through Nov 2025 reached $127353.0, down 65.15%, while the annual FY2025 figure was $303022.0, 21.77% up from the prior year.
  • Revenue for Q4 2025 was $53266.0 at Cannabis Bioscience International Holdings, up from $24200.0 in the prior quarter.
  • Across five years, Revenue topped out at $178887.0 in Q3 2024 and bottomed at -$36278.0 in Q4 2022.
  • The 4-year median for Revenue is $51252.0 (2023), against an average of $53131.8.
  • The largest annual shift saw Revenue skyrocketed 275.72% in 2023 before it tumbled 86.47% in 2025.
  • A 4-year view of Revenue shows it stood at -$36278.0 in 2022, then surged by 275.72% to $63748.0 in 2023, then increased by 16.47% to $74248.0 in 2024, then dropped by 28.26% to $53266.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Revenue are $53266.0 (Q4 2025), $24200.0 (Q3 2025), and $34956.0 (Q2 2025).